MOLECULAR AND CELLULAR ENDOCRINOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2025-01-03 ms3000000843354882 来自江苏省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：代谢;子代代谢
经验分享：2024/06/03 submit –under review
2024/07/17 required reviews completed
2024/08/01 conditionally rejected（给机会大修）
2024/10/09 submit major revision
2024/11/10 minor revision
2024/11/19 submit minor revision
2024/12/14 accept
2024/12/28 proof

16 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2023-09-14 632005764 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：生殖内分泌
经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。

137 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2023-05-09 IWNMY 来自江苏省

请问这个杂志只能有一个通讯作者吗？

107 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

期刊可以有几个通讯作者/第一作者？

114 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

所有作者在文章接收之后都会接收到邮件吗？

126 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2020-10-20 zzzzfffvvv

非常专业的杂志，要求研究做的较深。

217 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

继续努力

256 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2019-10-13 ms4039545388929122

评审挺专业的，估计是内容不符吧，被拒了

284 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2019-08-19 颠疯

请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表::
2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表:
2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收

189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收

258 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2246319, encodeId=09ad2246319fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;子代代谢 经验分享：2024/06/03 submit –under review 2024/07/17 required reviews completed 2024/08/01 conditionally rejected（给机会大修） 2024/10/09 submit major revision 2024/11/10 minor revision 2024/11/19 submit minor revision 2024/12/14 accept 2024/12/28 proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=645f8464354, createdName=ms3000000843354882, createdTime=Fri Jan 03 10:56:31 CST 2025, time=2025-01-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2157747, encodeId=d83f215e74701, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生殖内分泌 经验分享：editor喜欢给 conditional rejected，但是又可以revise回去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Thu Sep 14 22:09:30 CST 2023, time=2023-09-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2131158, encodeId=dea32131158f8, content=请问这个杂志只能有一个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97481704305, createdName=IWNMY, createdTime=Tue May 09 15:22:37 CST 2023, time=2023-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1095121, encodeId=72e0109512131, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095122, encodeId=7a151095122cd, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893376, encodeId=d5128933e6f1, content=非常专业的杂志，要求研究做的较深。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Oct 20 20:10:11 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578683, encodeId=3aad5e868302, content=继续努力, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854239, encodeId=809f854239ea, content=评审挺专业的，估计是内容不符吧，被拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da25414074, createdName=ms4039545388929122, createdTime=Sun Oct 13 14:41:18 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574991, encodeId=64615e49913e, content=请问你的文章投稿后就好送外审的？^_^189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收189P3xP8469(暂无昵称) 2019-01-11 00:00:00 发表: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=189P3xP8469(暂无昵称) 2019-01-11 发表:: 2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46cc2404186, createdName=颠疯, createdTime=Mon Aug 19 00:00:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565437, encodeId=b12456543e83, content=2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5232388566, createdName=1232bc4bm69(暂无昵称), createdTime=Fri Jan 11 00:00:00 CST 2019, time=2019-01-11, status=1, ipAttribution=)]

2019-01-11 1232bc4bm69(暂无昵称)

2018.9.30投的 2018.11.4一审意见回来状态是revise 后面decision是conditionally rejected 给两个月时间补一些小实验 2018.12.27修回 2019.1.10接收

297 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务